Researchers test stronger antibiotic dose in race against deadly sepsis
NCT ID NCT07245966
Summary
This study tested whether giving a higher dose of the common antibiotic ceftriaxone could better control severe bloodstream infections (sepsis) in adults. Researchers measured how long the drug stayed at a high enough level in the blood to effectively kill bacteria. The goal was to find the best dose to help fight the infection more effectively in critically ill patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
Conditions
Explore the condition pages connected to this study.